Dr. Marika Lanza has completed master's degree in Biotechnology for health at the University of Messina in 2011. Dr. Marika Lanza has completed her PhD in “Clinical and Translational Research in Neuroscience and Oncology” in the year 2016 by University of Messina. Additionally, she performed postdoctoral studies at University of Messina. She worked as researcher for studies on pharmacology activities and molecular analysis (in vitro primary cultures and in vivo experimental models), for the Epitech Group and Radikal. Now she is a Researcher in Molecular Biology at the University of Messina. She has published more than 70 articles in reputed journals about biomarkers, molecular pathways, oxidative stress, inflammation and natural compound. Her research is involved in preclinical studies for the discovery of new biomarkers. Dr. Marika Lanza have knowledge about animals research, biochemical and molecular biology, immunohistochemical and immunofluorescence analysis.